Clinical Trial Update: PK of Efavirenz & Lopinavir Nano-formulations in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 study assessing the pharmacokinetics of nano-formulated efavirenz and lopinavir in healthy volunteers has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Kaletra (lopinavir) (lopinavir)
• Sustiva (efavirenz) (efavirenz)

Snippet

Sponsor: St Stephens Aids Trust | Conditions: HIV | Phase 1 | Status: SUSPENDED